| |
|
Injectables
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
| Aminophylline |
 Fiche signalétique
|
Visuel descriptif
|
Monographie
|
|
|
| |
Description |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
 |
Aminophylline injectable USP |
|
Relaxants respiratoires des muscles souples (86:16.00)
|
|
 
|
250mg/10mL (25mg/mL)
|
00582662 |
L0010021 |
10 |
|
|
| |
500mg/10mL (50mg/mL) |
00582654 |
L0010022 |
10 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
|
Benztropine OMEGA
|
Fiche signalétique
|
Visuel descriptif
|
Monographie
|
|
|
| |
Description |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
| |
Injection de mésylate de benztropine USP
|
|
Agents antiparkinsoniens
(12:08:04)
|
|
|
2mg/2mL (1mg/mL)
|
02238903 |
L0010081 |
10 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
| Calciject® |
Fiche signalétique
|
Visuel descriptif
|
Monographie
|
|
|
| |
Description |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
| |
Chlorure de calcium pour injection USP, 100mg/mL |
|
Préparations de substitution (40:12)
|
|
|
1000mg/10mL (100mg/mL)
|
00821780 |
L0010058 |
10 |
|
|
| |
5000mg/50mL (100mg/mL) |
00821780 |
L0010059 |
10 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
| Dexaméthasone OMEGA |
Fiche signalétique
|
Visuel descriptif
|
Monographie |
|
|
| |
Description |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
| |
Injection de phosphate sodique de dexaméthasone USP
|
|
Agents surrénaliens (68:04)
|
|
|
4mg/1mL (4mg/mL)
|
02204266 |
L0010026 |
10 |
|
|
| |
20mg/5mL (4mg/mL) |
02204266 |
L0010066 |
5 |
|
|
| |
100mg/25mL (4mg/mL) |
02204266 |
L0010036 |
10 |
|
|
| |
10mg/1mL (10mg/mL) |
02204274 |
L0010094 |
10 |
|
|
| |
100mg/10mL (10mg/mL) |
02204274 |
L0010067 |
1 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
| Sclérodex® |
Fiche signalétique
|
Visuel descriptif
|
Monographie |
|
|
| |
Description |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
| |
Dextrose USP 250 mg/mL (2500 mg/10 mL) et
chlorure de sodium USP 100 mg/mL (1000 mg/10 mL) |
|
Agents sclérosants
(24:16)
|
|
|
10mL
|
02020939 |
L0010035 |
5 |
|
|
| |
10mL
|
02020939
|
L0010034
|
50 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
| Diphenist® |
Fiche signalétique
|
Visuel descriptif
|
Monographie
|
|
|
| |
Description |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
 |
Injection de chlorhydrate de diphénhydramine USP
|
|
Dérivés éthanolamine
(04:04:04)
|
|
|
50mg/1mL (50mg/mL)
|
02219336 |
L0010078 |
10 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
| Famotidine OMEGA |
Fiche signalétique
|
Visuel descriptif
|
Monographie |
|
|
| |
Description |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
| |
Injection de famotidine
|
|
Divers agents GI (56:40)
Dist. par Hospira au Canada |
|
|
20mg/2mL (10mg/mL)
|
02247735 |
L0010106 |
10 |
|
|
| |
40mg/4mL (10mg/mL) -multidose |
02247745 |
L0010107 |
1 |
|
|
| |
200mg/20mL (10mg/mL) -multidose |
02247745 |
L0010031 |
1 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
| Fluphénazine OMEGA |
Fiche signalétique
|
Visuel descriptif
|
Monographie |
|
|
| |
Description |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
| |
Injection de décanoate de fluphénazine BP
|
|
Agents antipsychotiques (28:16.08)
|
|
|
100mg/1mL (100mg/mL)
|
02242570 |
L0010087 |
5 |
|
|
| |
125mg/5mL (25mg/mL) |
02239636 |
L0010086 |
1 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
Furosémide injection
|
Fiche signalétique
|
Visuel descriptif
|
Monographie
|
|
|
| |
Descritpion |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
| |
Furosémide injection
|
|
Diurétiques de l'anse (40:28:08)
|
|
|
20mg/2mL (10mg/mL)
|
02360365 |
L0010210 |
10 |
|
|
| |
40mg/4mL (10mg/mL) |
02360365 |
L0010211 |
10 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Furosémide pour injection
|
Fiche signalétique
|
Visuel descriptif
|
Monographie
|
|
|
| |
Descritpion |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
| |
Furosémide spécial injection
|
|
Diurétiques de l'anse (40:28:08)
|
|
| |
250mg/25mL (10mg/mL) |
02360446 |
L0010212 |
10 |
|
|
| |
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
Granisétron
|
Fiche signalétique
|
Visuel descriptif
|
Monographie |
|
|
| |
Description |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
| |
Chlorhydrate de granisétron injectable
|
|
Antagoniste des récepteurs 5-HT3 (56:22.20)
|
|
|
1mg/1mL (1mg granisétron/mL)
|
02322765 |
L0010140 |
5 |
|
|
| |
4mg/4mL (1mg granisétron/mL) |
02322765 |
L0010141
|
1 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Halopéridol-LA OMEGA |
Fiche signalétique
|
Visuel descriptif
|
Monographie |
|
|
| |
Description |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
| |
Injection de décanoate d’halopéridol
|
|
Agents antipsychotiques (28:16.08)
|
|
|
250mg/5mL (50mg/mL)
|
02239639 |
L0010088 |
1 |
|
|
| |
100mg/1mL (100mg/mL) |
02239640 |
L0010095 |
5 |
|
|
| |
500mg/5mL (100mg/mL) |
02239640 |
L0010089 |
1 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
Halopéridol injection
|
Fiche signalétique
|
Visuel descriptif
|
Monographie
|
|
|
| |
Description |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
| |
Halopéridol injection
|
|
Butyrophénones
(28:16:08.08)
|
|
|
5mg/1mL (5mg/mL)
|
02366010 |
L0010155 |
10 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
| RAN-Imipenem-Cilastatin |
Fiche signalétique
|
Visuel descriptif
|
Monographie |
|
|
| |
Description |
DIN |
CODE |
U/Boîte |
Classification AHSF |
|
| |
Imipénem-cilastatine pour injection USP
|
|
Carbapénèmes
(08:12.07.08)
Fabriqué par Ranbaxy
|
|
|
250/250mg
|
02351692 |
L0010232 |
30 |
|
|
| |
500/500mg |
02351706 |
L0010233 |
30 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
| Sclérodine® 6 |
Fiche signalétique
|
Visuel descriptif
|
Monographie |
|
|
| |
Description |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
| |
Iode USP 60mg/mL (600mg/10mL) et iodure de sodium USP 90mg/mL (900mg/10mL). |
|
Agents sclérosants
(24:16)
|
|
|
10mL
|
02020793 |
L0010037 |
5 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
| Méthylène bleu |
Fiche signalétique
|
Visuel descriptif
|
Monographie |
|
|
| |
Description |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
| |
Injection de bleu de méthylène USP
|
|
Agents thérapeutiques divers (92:00)
|
|
|
10mg/1mL (10mg/mL)
|
02230770 |
L0010085 |
10 |
|
|
| |
50mg/5mL (10mg/mL) |
02230770 |
L0010072 |
10 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
| Néostigmine OMEGA |
Fiche signalétique
|
Visuel descriptif
|
Monographie |
|
|
| |
Description |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
| |
Injection de méthylsulfate de néostigmine USP
|
|
Agents parasympatho-mimétiques (12:04)
|
|
|
0.5mg/1mL (0.5mg/mL)
|
02230593 |
L0010097 |
10 |
|
|
| |
5mg/10mL (0.5mg/mL)
|
02230593 |
L0010098 |
10 |
|
|
| |
10mg/10mL (1mg/mL) |
02230592 |
L0010096 |
10 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
| Nitroject® |
Fiche signalétique
|
Visuel descriptif
|
Monographie |
|
|
| |
Description |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
| |
Nitroglycérine injection USP
|
|
Agents vasodilatateurs (24:12)
|
|
|
10mg/10mL (1mg/mL)
|
00614262 |
L0010030 |
5 |
|
|
| |
50mg/10mL (5mg/mL)
|
00778869 |
L0010046 |
5 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Octréotide Acétate OMEGA |
Fiche signalétique
|
Visuel descriptif
|
Monographie |
|
|
| |
Description |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
| |
Acétate d’octréotide injectable
|
|
Agents thérapeutiques divers (92:00)
Dist. par Hospira au Canada
|
|
|
50μg/1mL (50μg/mL)
|
02248639 |
L0010115 |
5 |
|
|
| |
100μg/1mL (100μg/mL)
|
02248640 |
L0010116 |
5 |
|
|
| |
500μg/1mL (500μg/mL)
|
02248641 |
L0010117 |
5 |
|
|
| |
1000μg/5mL (200μg/mL) multidose |
02248642 |
L0010118 |
1 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Paraldéhyde injectable BP |
Fiche signalétique
|
Visuel descriptif
|
Monographie |
|
|
| |
Description |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
| |
Paraldéhyde injectable BP
|
|
Anxiolytiques, sédatifs et hypnotiques divers
(28:24.92)
|
|
|
5mL
|
02366029 |
LPH20153 |
5 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Phényléphrine |
Fiche signalétique
|
Visuel descriptif
|
Monographie |
|
|
| |
Description |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
| |
Injection de chlorhydrate de phényléphrine USP
|
|
Vasopresseur (52:32)
|
|
|
10mg/1mL (10mg/mL - 1%)
|
02238400 |
L0010080 |
10 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
| Scopolamine |
Fiche signalétique
|
Visuel descriptif
|
Monographie |
|
|
| |
Description |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
| |
Injection de bromhydrate de scopolamine
|
|
Agents anticholinergique (12:08)
|
|
|
0.4mg/1mL (0.4mg/mL)
|
02242810 |
L0010083 |
10 |
|
|
| |
0.6mg/1mL (0.6mg/mL) |
02242811 |
L0010084
|
10 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
| Sodium Acétate OMEGA |
Fiche signalétique
|
Visuel descriptif
|
Monographie |
|
|
| |
Description |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
| |
Injection d’acétate de sodium USP
|
|
Préparations de substitution (40:12)
|
|
|
16.4g/50mL (328mg/mL)
|
02181746 |
L0010063 |
10 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Chlorure de sodium injection |
Fiche signalétique
|
Visuel descriptif
|
Monographie |
|
|
| |
Description |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
| |
Chlorure de sodium injection USP
|
|
Préparations de substitution (40:12)
|
|
|
90mg/10mL (9mg/mL - 0.9%)
|
02150204 |
L0010001 |
10 |
|
|
| |
270mg/30mL (9mg/mL - 0.9%) |
02150204 |
L0010071 |
10 |
|
|
| |
270mg/30mL (9mg/mL - 0.9%)
Bactériostatique |
00402249 |
L0010003 |
10 |
|
|
| |
450mg/50mL (9mg/mL - 0.9%) |
02150204 |
L0010029 |
10 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Chlorure de sodium pour injection
|
Fiche signalétique
|
Visuel descriptif
|
Monographie |
|
|
| |
Description |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
| |
Chlorure de sodium pour injection USP
|
|
Préparations de substitution (40:12)
|
|
| |
7020mg/30mL (234mg/mL - 23.4%) |
00402230 |
L0010004 |
10 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
| Saliject® |
Fiche signalétique
|
Visuel descriptif
|
Monographie |
|
|
| |
Description |
DIN |
CODE |
U/Boîte |
Classification AHFS |
|
| |
Salicylate de sodium pour injection Norme Omega
|
|
Agents sclérosants (24 :16)
|
|
|
5.7g/10mL (570mg/mL)
|
00623571 |
L0010040 |
5 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
| Tromboject® 1% & 3% |
Fiche signalétique
|
Visuel descriptif
|
Monographie |
|
|
| |
Description |
DIN |
CODE |
U/Boîte |
Classification AHF |
|
|
Injection de tétradécyl sulfate de sodium
|
|
Agents sclérosants
(24 :16)
|
|
|
20mg/2mL (10mg/mL - 1%)
|
00511234 |
L0010049 |
10 |
|
|
| |
60mg/2mL (30mg/mL - 3%)
|
00511226 |
L0010050 |
10
|
|
|
| |
150mg/5mL (30mg/mL - 3%) |
00511226 |
L0010051 |
5 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
| Thiamiject® |
Fiche signalétique
|
Visuel descriptif
|
Monographie |
|
|
| |
Description |
DIN |
CODE |
U/Boîte |
Classification AHFS
|
|
|
Injection de chlorhydrate de thiamine USP
|
|
Complexe de vitamine B
(88:08)
|
|
|
1000mg/10mL (100mg/mL)
|
02193221 |
L0010061 |
5 |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Eau pour injection
|
Fiche signalétique
|
Visuel descriptif
|
Monographie |
|
|
| |
Description |
DIN |
CODE |
U/Boîte |
Classification AHFs |
|
|
Eau stérile pour injection USP
|
|
Diluants (40:50)
|
|
|
10mL
|
00402257 |
L0010005 |
10 |
|
|
| |
50mL
|
00402257 |
L0010028 |
10
|
|
|
| |
30mL
Bactériostatique
|
02131536 |
L0010008 |
10 |
|
|
|
50mL
Bactériostatique
|
02131536 |
L0010009
|
10 |
|
|
| |
|
|
|
|
|
|
|
